PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.36%
Revenue growth above 1.5x QRVO's 6.05%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.05%
Gross profit growth 1.25-1.5x QRVO's 11.97%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
41.52%
EBIT growth of 41.52% while QRVO is zero. Bruce Berkowitz would see if small gains can be scaled further.
42.32%
Operating income growth under 50% of QRVO's 269.58%. Michael Burry would be concerned about deeper cost or sales issues.
40.25%
Net income growth under 50% of QRVO's 277.45%. Michael Burry would suspect the firm is falling well behind a key competitor.
43.18%
EPS growth under 50% of QRVO's 260.36%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
40.91%
Diluted EPS growth under 50% of QRVO's 277.42%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.93%
Share reduction while QRVO is at 4.92%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.91%
Reduced diluted shares while QRVO is at 0.18%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.31%
Dividend growth of 0.31% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
67.75%
OCF growth under 50% of QRVO's 196.98%. Michael Burry might suspect questionable revenue recognition or rising costs.
80.52%
FCF growth 50-75% of QRVO's 123.95%. Martin Whitman would see if structural disadvantages exist in generating free cash.
67.30%
10Y revenue/share CAGR above 1.5x QRVO's 37.96%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
58.50%
5Y revenue/share CAGR above 1.5x QRVO's 37.96%. David Dodd would look for consistent product or market expansions fueling outperformance.
2.76%
3Y revenue/share CAGR under 50% of QRVO's 37.96%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
152.27%
10Y OCF/share CAGR under 50% of QRVO's 946.26%. Michael Burry would worry about a persistent underperformance in cash creation.
64.60%
Below 50% of QRVO's 946.26%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.57%
3Y OCF/share CAGR under 50% of QRVO's 946.26%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
155.09%
Net income/share CAGR 1.25-1.5x QRVO's 133.33%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
210.77%
5Y net income/share CAGR above 1.5x QRVO's 133.33%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
9.70%
Below 50% of QRVO's 133.33%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
38.59%
Below 50% of QRVO's 86.79%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
34.39%
Below 50% of QRVO's 86.79%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
3.61%
Below 50% of QRVO's 86.79%. Michael Burry suspects a serious short-term disadvantage in building book value.
1337.84%
Dividend/share CAGR of 1337.84% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
174.90%
Dividend/share CAGR of 174.90% while QRVO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
132.42%
3Y dividend/share CAGR of 132.42% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.69%
AR growth well above QRVO's 24.55%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.75%
We show growth while QRVO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-5.94%
Negative asset growth while QRVO invests at 0.96%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.53%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-17.76%
We’re deleveraging while QRVO stands at 1.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.64%
Our R&D shrinks while QRVO invests at 1.82%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.46%
We cut SG&A while QRVO invests at 10.49%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.